| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | ambrisentan | FAERS: 3 | US FAERS | |
| 2 | Norgestrel | FAERS: 2 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 3 | Thalidomide | FAERS: 2 | US FAERS | |
| 4 | Bortezomib | FAERS: 1 | US FAERS | |
| 5 | Copper | FAERS: 1 | US FAERS | |
| 6 | Isotretinoin | FAERS: 1 | US FAERS | |
| 7 | Lenalidomide | FAERS: 1 | US FAERS | |
| 8 | NuvaRing | FAERS: 1 | US FAERS | |
| 9 | Ortho Evra | FAERS: 1 | US FAERS | |
| 10 | etonogestrel | FAERS: 1 | US FAERS | |
| 11 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.